Skip to content

Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial

Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start on Highly Active Antiretroviral Therapy: a Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00429845
Enrollment
80
Registered
2007-02-01
Start date
2004-03-31
Completion date
2007-02-28
Last updated
2007-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

HIV, HAART, Nutrition, Dyslipidemia

Brief summary

Highly active antiretroviral therapy (HAART) in HIV-positive patients is associated with the development of dyslipidemia, a risk factor for cardiovascular events. The objective of this study was to evaluate the effect of dietary intervention in individuals who start HAART.

Detailed description

Adult patients prescribed to HAART that met the exclusion criteria were consecutively enrolled in a randomized trial: * control (receiving general guidelines on dietary education) * intervention (receiving general guidelines on dietary education and nutritional follow-up every 3 months)

Interventions

BEHAVIORALNutritional

Sponsors

Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* HIV-positive individuals naive to HAART, with clinical indication to start therapy

Exclusion criteria

* Diabetes Mellitus * Pregnancy * Active opportunistic disease * Any mental deficiency * Use of lipid profile influencing drugs * Use of illicit drugs

Design outcomes

Primary

MeasureTime frame
Total cholesterol and of triglycerides levels

Secondary

MeasureTime frame
HDL-cholesterol, LDL-cholesterol, weight, waist to hip ratio

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026